Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CDIB BioScience Venture Management (CBVM) is a specialized venture capital firm focused on the global life sciences and healthcare industries. As a subsidiary of China Development Financial, one of Taiwan's largest financial groups, CBVM manages dedicated funds that invest in biotechnology, pharmaceuticals, medical devices, and diagnostics. The firm primarily targets high-growth opportunities in the United States, Taiwan, and Greater China, facilitating cross-border collaborations and market entry. CBVM's investment strategy spans from early-stage venture rounds to late-stage growth capital, supporting companies through critical development milestones. With a team of experienced scientists and financial professionals, the firm provides strategic guidance and access to an extensive international network. Their portfolio has historically included notable successes in oncology, infectious diseases, and advanced medical technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CDIB BioScience Venture Management.